update on tirzepatide lawsuit Eli Lilly joins FDA as Defendant in Over Shortage Zepbound Lawsuit | Individual and

Youve finally found your rhythm with tirzepatide, the cravings are fading, the scale is moving, and your energys coming back

Initial tolerance not yet a therapeutic dose for weight loss First therapeutic dose appetite reduction begins noticeably Significant appetite suppression for most patients Many patients reach goal weight at this dose Advanced dose for patients needing additional weight loss Highest approved dose 22.5% avg weight loss in trials Dose increases are made every 4 weeks minimum, though your provider may hold at a dose longer if you are responding well or experiencing side effects

They will give you a full medical assessment and overview to ensure its the right option for you

Good skin care happens all in good time

GLP-1 RAs are established treatments for type 2 diabetes and obesity due to their potent glucose-lowering, appetite-suppressing, and weight-loss effects